FMR LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$91,864,371
-13.3%
5,788,555
+3.1%
0.01%
-11.1%
Q2 2023$105,912,442
+1049.9%
5,612,742
+134.0%
0.01%
Q1 2023$9,210,426
+55.1%
2,398,548
+100.3%
0.00%
-100.0%
Q4 2022$5,938,226
+12.4%
1,197,223
+8.3%
0.00%0.0%
Q3 2022$5,285,000
+6.6%
1,105,729
+0.3%
0.00%
Q2 2022$4,959,000
-91.4%
1,101,983
-90.9%
0.00%
-100.0%
Q1 2022$57,474,000
-36.9%
12,074,343
-1.6%
0.01%
-28.6%
Q4 2021$91,079,000
+38.9%
12,274,823
+6.1%
0.01%
+40.0%
Q3 2021$65,573,000
-13.3%
11,564,887
+0.8%
0.01%
-16.7%
Q2 2021$75,624,000
-31.0%
11,475,530
-15.2%
0.01%
-33.3%
Q1 2021$109,627,000
+35.5%
13,534,350
+7.9%
0.01%
+28.6%
Q4 2020$80,900,000
+1327.8%
12,542,614
+696.8%
0.01%
+600.0%
Q3 2020$5,666,000
-21.7%
1,574,061
+0.0%
0.00%0.0%
Q2 2020$7,240,000
+34.9%
1,573,863
+0.0%
0.00%0.0%
Q1 2020$5,366,000
+39.6%
1,573,748
+108.9%
0.00%
Q4 2019$3,845,000
+384400.0%
753,199
+171081.6%
0.00%
Q3 2019$1,0000.0%440
+21.9%
0.00%
Q2 2019$1,000
-100.0%
361
-100.0%
0.00%
-100.0%
Q1 2019$4,598,000
-85.1%
1,696,894
-73.6%
0.00%
-75.0%
Q4 2018$30,855,000
-56.5%
6,427,984
-14.3%
0.00%
-50.0%
Q3 2018$71,002,000
-16.2%
7,497,597
-13.9%
0.01%
-20.0%
Q2 2018$84,692,000
+23.9%
8,704,234
+34.0%
0.01%
+25.0%
Q1 2018$68,332,000
+90.2%
6,495,438
+15.9%
0.01%
+100.0%
Q4 2017$35,930,000
-16.2%
5,605,2850.0%0.00%
-20.0%
Q3 2017$42,880,000
+7.6%
5,605,2850.0%0.01%0.0%
Q2 2017$39,854,000
+1184.0%
5,605,285
+598.9%
0.01%
Q1 2017$3,104,000
+89.7%
802,0290.0%0.00%
Q4 2016$1,636,000
-72.2%
802,029
-63.4%
0.00%
-100.0%
Q3 2016$5,878,000
-40.7%
2,193,246
-31.9%
0.00%0.0%
Q2 2016$9,917,000
-78.9%
3,219,829
-41.6%
0.00%
-85.7%
Q1 2016$46,985,000
-43.0%
5,514,629
-9.3%
0.01%
-36.4%
Q4 2015$82,461,000
+18.4%
6,076,729
-16.3%
0.01%
+10.0%
Q3 2015$69,669,000
-45.9%
7,257,201
-19.0%
0.01%
-41.2%
Q2 2015$128,838,000
+58.4%
8,959,497
-1.4%
0.02%
+70.0%
Q1 2015$81,347,000
+41.6%
9,089,083
-3.5%
0.01%
+42.9%
Q4 2014$57,442,000
-47.1%
9,416,641
-8.2%
0.01%
-53.3%
Q3 2014$108,656,000
-21.2%
10,260,241
-11.9%
0.02%
-16.7%
Q2 2014$137,945,000
-24.2%
11,640,950
-4.5%
0.02%
-28.0%
Q1 2014$181,973,000
+1.9%
12,188,461
+0.1%
0.02%0.0%
Q4 2013$178,618,000
-17.7%
12,175,738
-4.5%
0.02%
-24.2%
Q3 2013$217,093,000
+3.2%
12,755,138
+0.6%
0.03%
-2.9%
Q2 2013$210,362,00012,680,0710.03%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders